Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study.
Bianco
J A
JA
Division of Oncology Clinical Research, Veterans Affairs Medical Center, Seattle, Washington 98108.
Almgren
J
J
Kern
D L
DL
Ballard
B
B
Roark
K
K
Andrews
F
F
Nemunaitis
J
J
Shields
T
T
Singer
J W
JW
D000284:Administration, Oral; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D003524:Cyclosporins / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology; D010431:Pentoxifylline / Q000008:administration & dosage*; D010865:Pilot Projects; D011446:Prospective Studies; D014184:Transplantation, Homologous / Q000706:statistics & numerical data
D003524:Cyclosporins; D000666:Amphotericin B; D010431:Pentoxifylline